SMECTA

This brand name is authorized in Ecuador, Estonia, France, Hong Kong SAR China, Lithuania, Poland, Romania, Singapore, Tunisia.

Active ingredients

The drug SMECTA contains one active pharmaceutical ingredient (API):

1	Diosmectite UNII A585MN1H2L - MONTMORILLONITE
	Diosmectite is a natural aluminomagnesium silicate clay with a lamellar, non-fibrous crystalline structure that gives it strong adsorbent properties. Diosmectite has demonstrated efficacy in the treatment of acute watery diarrhoea in children.
	Read more about Diosmectite

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07BC05	Diosmectite	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07B Intestinal adsorbents → A07BC Other intestinal adsorbents
Discover more medicines within A07BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	3021-MEE-0917
EE	Ravimiamet	1028472, 1063640
FR	Base de données publique des médicaments	64450063, 69584073
HK	Department of Health Drug Office	34268
LT	Valstybinė vaistų kontrolės tarnyba	1010356, 1010357, 1063704, 1063705, 1092607
PL	Rejestru Produktów Leczniczych	100016564, 100061530, 100266321, 100268662, 100334620, 100343027, 100358945, 100426836, 100455849
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66204002, W66204003
SG	Health Sciences Authority	06338P
TN	Direction de la Pharmacie et du Médicament	5720011